Page 73 - Looking Statement News Today

Press release content from Business Wire. The AP news staff was not involved in its creation.

/PRNewswire/ -- Trutankless, Inc. (OTCQB: TKLS) today announced its intention to spin-off its wholly-owned subsidiary, Notation Labs, Inc. The subsidiary...

Press release content from PR Newswire. The AP news staff was not involved in its creation.

/PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today...

VANCOUVER, BRITISH COLUMBIA TheNewswire - November 1, 2021 US Newrange Gold Corp. is pleased to announce that it has closed the acquisition of a 100% interest in the past-producing, high-grade Argosy Gold Mine in the Red Lake Mining Division of northwestern Ontario as previously disclosed in Newrange press release dated August 5, 2021 . Pursuant to the acquisition, the Company acquired all of the shares of Cangold ...

VANCOUVER, BRITISH COLUMBIA TheNewswire - November 2, 2021 Newrange Gold Corp. is pleased to provide additional information on its wholly owned Argosy Gold Mine in the Red Lake Mining Division of northwestern Ontario .  As announced on November 1, the Company has acquired a 100% interest in the mine property from Great Panther Mining Limited through the acquisition of its subsidiary, Cangold Limited. The Argosy ...

/PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced financial results for the three months ended September 30, 2021 and provided a corporate...

KEYTRUDA Continued To Improve Recurrence-Free Survival Compared to Placebo as Adjuvant Therapy for Patients With Resected Stage IIB or IIC Melanoma at 2 nd Interim Analysis of Phase 3 KEYNOTE-716 Trial Exploratory 7-Year Follow-Up Data for KEYTRUDA in Advanced Melanoma Showed 38% of Patients Treated With KEYTRUDA Were Alive at 7 Years Merck known as MSD outside the United States and Canada, today announced new data ...

Merck, Ridgeback Biotherapeutics and Emory University Will Not Receive Royalties for Sales of Molnupiravir Under this Agreement for as Long as COVID-19 Remains Classified as a Public Health Emergency of International Concern by the World Health Organization Collaboration Continues Merck’s Long Track Record of Making Its Medicines and Vaccines Accessible and Affordable Globally This is the First MPP Agreement to ...

MSD, Ridgeback Biotherapeutics and Emory University will not receive royalties for sales of molnupiravir under this agreement for as long as COVID-19 remains classified as a Public Health Emergency